NEW YORK (GenomeWeb News) – Caprion Proteomics said today that it is working with Applied Biosystems to verify and validate protein biomarker candidates for use in clinical settings.

Caprion said it is using the Life Technologies division's QTRAP technology to develop and deploy multiple reaction monitoring (MRM) assays to validate biomarker candidates. The QTRAP technology is used to integrate quantitative and qualitative analysis through the MIDAS workflow and fast MRM assay development and quantitative results, said Caprion.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.